. /.WORLD TRADE
ORGANIZATIONG/TBT/N/THA/86
19 September 2002
(02-5005)
Committee on Technical Barriers to Trade Original:  English
NOTIFICATION
The following notification is being circulated in accordance with Article 10.6.
1. Member to Agreement notifying:   THAILAND
If applicable, name of local government involved (Articles 3.2 and 7.2):           
2. Agency responsible:   Department of Foreign Trade, Ministry of Commerce          
Name and address (including telephone and fax numbers, e-mail and web-site
addresses, if available) of  agency or authority designated to handle comments
regarding the notification shall be indicated if different from above:   Thai Industrial
Standards Institute (TISI), Tel: (66 2) 2023512  Fax: (66 2) 2478734,  Email:
thaistan@tisi.go.th, stdinfo@tisi.go.th, website address:  www.tisi.go.th
3. Notified under Article 2.9.2 [  X ], 2.10.1 [    ], 5.6.2 [    ], 5.7.1 [    ], other:           
4. Products covered (HS or CCCN where applicable, otherwise national tariff heading.
ICS numbers may be provided in addition, where applicable):    Pharmaceutical products
(HS Chapter 30, ICS: 11.120 Pharmaceutics)
5. Title, number of pages and language(s) of the notified document: Notification of the
Ministry of Commerce on Importation of Medicaments, Pharmaceutical Products and theirsalts and semi-finished Pharmaceutical Products into the Kingdom B.E.2545(2002)
(2 pages, available in Thai language)
6. Description of content:   This ministerial notification prescribes that the following
medicaments, pharmaceutical products and their salts, and semi-finished pharmaceutical
products are goods subject to import licencing and import prohibition unless approved from
the Minister of Commerce or his appointee:
(1)   Aristolochia spp.
(2)   Chloramphenicol
(3)   Chloroform(4)   Chlorpromazine
(5)   Colchicin
(6)   Dapsone
(7)   Nitrofurans
(8)   DiethylstrillbestrolG/TBT/N/THA/86
Page 2
(9)   Sulfonamides
(10)  Fluroquinolones
(11)  Glycopeptides
(12)  Dimetridazole
(13)  Metronidazole(14)  Ronidazole
(15)  Ipronidazole
(16)  Medicaments, pharmaceutical products and their salts, and other semi-finished
pharmaceutical products in Nitroimidazoles group.
Importers of such products must be officially approved from the Food and Drug
Administration, Ministry of Public Health exce pt for item (3) which must be approved from
Department of Industrial works, Ministry of Industry.  Such evidences shall be submitted tothe Department of Foreign Trade, Ministry of Commerce and shall be approved by the
Minister of Commerce or his appointee prior to importation.
7. Objective and rationale, including the na ture of urgent problems where applicable:
Consumer protection
8. Relevant documents:
Publication in which the notification is published when adopted:  Government Gazette,
Vol.119, Special Part 45 ngor., dated 24 May 2002
9. Proposed date of adoption :                   22 May 2002
Proposed date of entry into force :        25 May 2002
10. Final date for comments:   60 days from the circulation date
11. Texts available from:  National enquiry point [  X ] or address, telephone and fax
numbers, e-mail and web-site addresses, if available of the other body:           